Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry G. who wrote (424)	2/14/1999 9:32:00 AM
From: Taff	Read Replies (1) of 792

Does anyone follow BRA:TSE or Nasdaq:BIOMF Just doing my sunday morning research and stumbled across this one. Here is what I found, if anyone has a comment i would appreciate hearing from you, Thanks in advance Taff Biomira's lead product is Theratope,which the company describes as an anti-breast cancer vaccine, but which might be more easily understood by the layman as a drug. Theratope is a therapeutic agent, meaning that it is designed to treat active cases of the disease. It works by teaching the body's immune system to recognize and fight diseased cells. If Biomira's claims with respect to its vaccine are borne out, that revenue could add up to an avalanche of money. Breast cancer is a leading cause of death worldwide so the market for a successful drug would be huge. The company has built a solid drug pipeline, with a string of therapies under development that could become major revenue earners. If you use charting, see below. It looks to be over bought at this time. Volume is normal. Might be worth a wait and see IMO iqc.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next